Cervical screening in England: The past, present, and future

被引:45
|
作者
Albrow, Rebecca [2 ]
Kitchener, Henry [2 ]
Gupta, Nalini [3 ]
Desai, Mina [1 ]
机构
[1] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Cytol Ctr, Manchester Royal Infirm, Manchester M13 9WL, Lancs, England
[2] Univ Manchester, Sch Canc & Enabling Sci, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[3] Postgrad Inst Med Educ & Res, Dept Cytol & Gynaecol Pathol, Chandigarh 160012, India
关键词
cervical intraepithelial neoplasia; mass screening; vaginal smears; papillomavirus infections; RANDOMIZED CONTROLLED-TRIAL; FOLLOW-UP; CYTOLOGY; CANCER; WOMEN; TERMINOLOGY; HISTORIES; WORKING; UK;
D O I
10.1002/cncy.20203
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Cervical screening in England commenced in a disorganized fashion in 1964. The flaws of this approach became apparent in the mid-1980s and led to the inception of the National Health Service Cervical Screening Programme (NHSCSP). The main features of this program are its population-based registry, accessibility to all women within the screening age range, its systematic process of call and recall, national coordination, and quality assurance. Its success is in part based on its ability to evolve as evidence necessitates, and throughout the period of 2000-2010, it embarked upon a series of developments involving liquid-based cytology, which also provided the means to conduct reflex high-risk human papillomavirus (HR-HPV) testing and the potential to automate the screening process. As a result of evidence acquired since 2000, the NHSCSP is currently based on a system of primary cytology with HPV triage for low-grade abnormalities combined with cytology plus a HR-HPV test of cure for women who have received treatment for cervical intraepithelial neoplasia. Future challenges for the program will involve finding solutions to increasing screening uptake among women <30 years of agea problem that may be exacerbated when vaccinated women reach the screening age, while making plans to accommodate HPV primary screening. Cancer (Cancer Cytopathol) 2012;. (c) 2012 American Cancer Society.
引用
收藏
页码:87 / 96
页数:10
相关论文
共 50 条
  • [41] Pulmonary nodules and CT screening: the past, present and future
    Ruparel, M.
    Quaife, S. L.
    Navani, N.
    Wardle, J.
    Janes, S. M.
    Baldwin, D. R.
    THORAX, 2016, 71 (04) : 367 - 375
  • [42] Biomarkers in prostate cancer surveillance and screening: past, present, and futureBiomarkers in prostate cancer surveillance and screening: past, present, and future
    Cary, K. Clint
    Cooperberg, Mathew R.
    THERAPEUTIC ADVANCES IN UROLOGY, 2013, 5 (06) : 318 - 329
  • [43] The Present and Future of Cervical Cancer Screening Programmes in Europe
    Rossi, Paolo Giorgi
    Ronco, Guglielmo
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (08) : 1490 - 1497
  • [44] CERVICAL-SPINE SURGERY - PAST, PRESENT, AND FUTURE POTENTIAL
    FIELDING, JW
    CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 1985, (200) : 284 - 290
  • [45] CERVICAL-SPINE SURGERY - PAST, PRESENT, AND FUTURE POTENTIAL
    FIELDING, JW
    HENSINGER, RN
    ORTHOPEDICS, 1987, 10 (12) : 1701 - 1705
  • [46] POULTRY-INDUSTRY IN ENGLAND AND WALES-PAST, PRESENT AND FUTURE
    GRIFFIS, DO
    JOURNAL OF THE ROYAL AGRICULTURAL SOCIETY OF ENGLAND, 1973, 134 : 37 - 46
  • [47] COMMUNITY POLICING IN ENGLAND, WALES, AND EUROPEAN UNION: PAST, PRESENT AND FUTURE
    Pala, Erkan
    Balcioglu, Ercan
    ANKARA AVRUPA CALISMALARI DERGISI-ANKARA REVIEW OF EUROPEAN STUDIES, 2016, 15 (01): : 173 - 199
  • [48] Informed consent for expanded carrier screening: Past, present, and future
    Rink, Britton D.
    PRENATAL DIAGNOSIS, 2023, 43 (04) : 489 - 495
  • [49] Phenotypic screening in cancer drug discovery — past, present and future
    John G. Moffat
    Joachim Rudolph
    David Bailey
    Nature Reviews Drug Discovery, 2014, 13 : 588 - 602
  • [50] Novel organoid model in drug screening: Past, present, and future
    Nie, Xialin
    Liang, Zhixing
    Li, Kun
    Yu, Haoyuan
    Huang, Yuhan
    Ye, Linsen
    Yang, Yang
    LIVER RESEARCH, 2021, 5 (02) : 72 - 78